Ascend Wellness Holdings (AAWH) Total Non-Current Liabilities (2021 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Total Non-Current Liabilities of $27.6 million for Q1 2026, up 37.32% year-over-year from $20.1 million in Q1 2025, and up 24.62% quarter-over-quarter from $22.1 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Total Non-Current Liabilities (2021 - 2026) Analysis & Trends
Ascend Wellness Holdings' Total Non-Current Liabilities history runs 6 years deep, the most recent figure standing at $27.6 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 37.32% year-over-year to $27.6 million; the TTM figure through Mar 2026 stood at $27.6 million (up 37.32% YoY), while the FY2025 annual figure was $22.1 million, up 59.01% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $27.6 million, up from $22.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $717.5 million in Q2 2023, with the low at $9.3 million in Q1 2024.
- The 5-year median for Total Non-Current Liabilities is $20.7 million (2025), against an average of $123.1 million.
- The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities surged 523.93% in 2023, then tumbled 98.69% in 2024.
- Ascend Wellness Holdings' Total Non-Current Liabilities stood at $115.0 million in 2022, then tumbled by 91.73% to $9.5 million in 2023, then soared by 46.3% to $13.9 million in 2024, then jumped by 59.01% to $22.1 million in 2025, then advanced by 24.62% to $27.6 million in 2026.
- Business Quant data shows AAWH's Total Non-Current Liabilities at $27.6 million in Q1 2026, $22.1 million in Q4 2025, and $26.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -13.28 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.45 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 11.64 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 33.50 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.76 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 1.37 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.42 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 334.00 Mn |
| 10 | Ascend Wellness Holdings | 95.41 Mn | 28.41 Mn | 45.49 Mn | 35.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 35.53 Mn |
| Mar 31, 2026 | 27.59 Mn |
| Dec 31, 2025 | 22.14 Mn |
| Sep 30, 2025 | 26.42 Mn |
| Jun 30, 2025 | 21.27 Mn |
| Mar 31, 2025 | 20.09 Mn |
| Dec 31, 2024 | 13.92 Mn |
| Sep 30, 2024 | 13.42 Mn |
| Jun 30, 2024 | 11.85 Mn |
| Mar 31, 2024 | 9.28 Mn |
| Dec 31, 2023 | 9.52 Mn |
| Sep 30, 2023 | 9.52 Mn |
| Jun 30, 2023 | 717.54 Mn |
| Mar 31, 2023 | 705.56 Mn |
| Jun 30, 2022 | 115.00 Mn |
| Dec 31, 2021 | 126.40 Mn |